vs
ALLEGRO MICROSYSTEMS, INC.（ALGM）与Apellis Pharmaceuticals, Inc.（APLS）财务数据对比。点击上方公司名可切换其他公司
ALLEGRO MICROSYSTEMS, INC.的季度营收约是Apellis Pharmaceuticals, Inc.的1.1倍（$229.2M vs $199.9M），ALLEGRO MICROSYSTEMS, INC.净利率更高（3.6% vs -29.5%，领先33.1%），ALLEGRO MICROSYSTEMS, INC.同比增速更快（28.9% vs -5.9%），过去两年ALLEGRO MICROSYSTEMS, INC.的营收复合增速更高（17.2% vs 7.7%）
Allegro微系统是一家全球性半导体设计制造企业，专注于研发生产高性能功率与传感类集成电路，核心产品覆盖磁传感器、功率IC、运动控制解决方案，广泛服务于汽车、工业、消费电子、通信等下游领域。
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
ALGM vs APLS — 直观对比
营收规模更大
ALGM
是对方的1.1倍
$199.9M
营收增速更快
ALGM
高出34.8%
-5.9%
净利率更高
ALGM
高出33.1%
-29.5%
两年增速更快
ALGM
近两年复合增速
7.7%
损益表 — Q2 FY2027 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $229.2M | $199.9M |
| 净利润 | $8.4M | $-59.0M |
| 毛利率 | 46.7% | — |
| 营业利润率 | 57.5% | -25.6% |
| 净利率 | 3.6% | -29.5% |
| 营收同比 | 28.9% | -5.9% |
| 净利润同比 | 369.0% | -62.2% |
| 每股收益（稀释后） | $0.04 | $-0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALGMAPLS
| Q3 26 | $229.2M | — | ||
| Q4 25 | $229.2M | $199.9M | ||
| Q3 25 | $214.3M | $458.6M | ||
| Q2 25 | $203.4M | $178.5M | ||
| Q1 25 | $192.8M | $166.8M | ||
| Q4 24 | $177.9M | $212.5M | ||
| Q3 24 | $187.4M | $196.8M | ||
| Q2 24 | $166.9M | $199.7M |
净利润ALGMAPLS
| Q3 26 | $8.4M | — | ||
| Q4 25 | $8.3M | $-59.0M | ||
| Q3 25 | $6.5M | $215.7M | ||
| Q2 25 | $-13.2M | $-42.2M | ||
| Q1 25 | $-14.8M | $-92.2M | ||
| Q4 24 | $-6.9M | $-36.4M | ||
| Q3 24 | $-33.7M | $-57.4M | ||
| Q2 24 | $-17.7M | $-37.7M |
毛利率ALGMAPLS
| Q3 26 | 46.7% | — | ||
| Q4 25 | 46.7% | — | ||
| Q3 25 | 46.3% | — | ||
| Q2 25 | 44.9% | — | ||
| Q1 25 | 41.4% | — | ||
| Q4 24 | 45.7% | — | ||
| Q3 24 | 45.7% | — | ||
| Q2 24 | 44.8% | — |
营业利润率ALGMAPLS
| Q3 26 | 57.5% | — | ||
| Q4 25 | 4.2% | -25.6% | ||
| Q3 25 | 2.9% | 48.7% | ||
| Q2 25 | -1.3% | -18.6% | ||
| Q1 25 | -6.8% | -50.0% | ||
| Q4 24 | -0.0% | -12.3% | ||
| Q3 24 | 2.2% | -24.0% | ||
| Q2 24 | -6.4% | -14.7% |
净利率ALGMAPLS
| Q3 26 | 3.6% | — | ||
| Q4 25 | 3.6% | -29.5% | ||
| Q3 25 | 3.0% | 47.0% | ||
| Q2 25 | -6.5% | -23.6% | ||
| Q1 25 | -7.7% | -55.3% | ||
| Q4 24 | -3.9% | -17.1% | ||
| Q3 24 | -18.0% | -29.2% | ||
| Q2 24 | -10.6% | -18.9% |
每股收益（稀释后）ALGMAPLS
| Q3 26 | $0.04 | — | ||
| Q4 25 | $0.04 | $-0.40 | ||
| Q3 25 | $0.03 | $1.67 | ||
| Q2 25 | $-0.07 | $-0.33 | ||
| Q1 25 | $-0.08 | $-0.74 | ||
| Q4 24 | $-0.04 | $-0.30 | ||
| Q3 24 | $-0.18 | $-0.46 | ||
| Q2 24 | $-0.09 | $-0.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $155.2M | $466.2M |
| 总债务越低越好 | $287.7M | — |
| 股东权益账面价值 | — | $370.1M |
| 总资产 | $1.4B | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALGMAPLS
| Q3 26 | $155.2M | — | ||
| Q4 25 | $155.2M | $466.2M | ||
| Q3 25 | $117.5M | $479.2M | ||
| Q2 25 | $129.1M | $370.0M | ||
| Q1 25 | $121.3M | $358.4M | ||
| Q4 24 | $138.5M | $411.3M | ||
| Q3 24 | $188.8M | $396.9M | ||
| Q2 24 | $173.1M | $360.1M |
总债务ALGMAPLS
| Q3 26 | $287.7M | — | ||
| Q4 25 | $280.7M | — | ||
| Q3 25 | $280.4M | — | ||
| Q2 25 | $304.8M | — | ||
| Q1 25 | $338.9M | — | ||
| Q4 24 | $368.7M | — | ||
| Q3 24 | $393.0M | — | ||
| Q2 24 | $195.8M | — |
股东权益ALGMAPLS
| Q3 26 | — | — | ||
| Q4 25 | $962.7M | $370.1M | ||
| Q3 25 | $944.2M | $401.2M | ||
| Q2 25 | $922.7M | $156.3M | ||
| Q1 25 | $929.6M | $164.2M | ||
| Q4 24 | $933.0M | $228.5M | ||
| Q3 24 | $937.3M | $237.1M | ||
| Q2 24 | $1.1B | $264.3M |
总资产ALGMAPLS
| Q3 26 | $1.4B | — | ||
| Q4 25 | $1.4B | $1.1B | ||
| Q3 25 | $1.4B | $1.1B | ||
| Q2 25 | $1.4B | $821.4M | ||
| Q1 25 | $1.4B | $807.3M | ||
| Q4 24 | $1.4B | $885.1M | ||
| Q3 24 | $1.5B | $901.9M | ||
| Q2 24 | $1.4B | $904.5M |
负债/权益比ALGMAPLS
| Q3 26 | — | — | ||
| Q4 25 | 0.29× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 0.36× | — | ||
| Q4 24 | 0.40× | — | ||
| Q3 24 | 0.42× | — | ||
| Q2 24 | 0.18× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-14.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-14.3M |
| 自由现金流率自由现金流/营收 | — | -7.1% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $45.0M |
8季度趋势，按日历期对齐
经营现金流ALGMAPLS
| Q3 26 | — | — | ||
| Q4 25 | $45.4M | $-14.2M | ||
| Q3 25 | $20.4M | $108.5M | ||
| Q2 25 | $61.6M | $4.4M | ||
| Q1 25 | $20.4M | $-53.4M | ||
| Q4 24 | $-8.2M | $19.4M | ||
| Q3 24 | $15.5M | $34.1M | ||
| Q2 24 | $34.2M | $-8.3M |
自由现金流ALGMAPLS
| Q3 26 | — | — | ||
| Q4 25 | $41.3M | $-14.3M | ||
| Q3 25 | $13.9M | $108.3M | ||
| Q2 25 | $51.0M | $4.4M | ||
| Q1 25 | $15.0M | $-53.4M | ||
| Q4 24 | $-21.8M | $19.3M | ||
| Q3 24 | $5.6M | — | ||
| Q2 24 | $23.2M | $-8.4M |
自由现金流率ALGMAPLS
| Q3 26 | — | — | ||
| Q4 25 | 18.0% | -7.1% | ||
| Q3 25 | 6.5% | 23.6% | ||
| Q2 25 | 25.1% | 2.5% | ||
| Q1 25 | 7.8% | -32.0% | ||
| Q4 24 | -12.3% | 9.1% | ||
| Q3 24 | 3.0% | — | ||
| Q2 24 | 13.9% | -4.2% |
资本支出强度ALGMAPLS
| Q3 26 | — | — | ||
| Q4 25 | 1.8% | 0.1% | ||
| Q3 25 | 3.0% | 0.0% | ||
| Q2 25 | 5.2% | 0.0% | ||
| Q1 25 | 2.8% | 0.0% | ||
| Q4 24 | 7.7% | 0.0% | ||
| Q3 24 | 5.3% | 0.0% | ||
| Q2 24 | 6.6% | 0.0% |
现金转化率ALGMAPLS
| Q3 26 | — | — | ||
| Q4 25 | 5.47× | — | ||
| Q3 25 | 3.12× | 0.50× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALGM
| Automotive | $164.5M | 72% |
| Industrial and Other | $64.7M | 28% |
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
